Safeguard in search for Euro distribution partner
This article was originally published in Clinica
Executive Summary
US-based Safeguard Medical Devices is looking for a partner to distribute its Disintegrator Plus home-use needle and lancet destroying device in Europe. The device, which is marketed mainly at diabetics, won FDA approval for home use in April and the company is expecting CE-Marking approval within the next couple of months. The American Diabetes Association, which has voiced concern over the dangers posed by the 3.6 billion syringes discarded in the US every year, has also given the device its stamp of approval.